David Jopke
Family · Tucson, AZNPI 1881372472
Payments from drug & device makers
Across 160 payments — averaging $53.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$4K
- Medtronic$2K
- Novo Nordisk$503
- Dexcom, Inc.$499
- Bayer$373
- Abbott$178
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$3,20037%
- Travel & lodging$1,23414%
- Food & beverage$4,10548%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 13 | $3,577 |
| Medtronic | 18 | $1,825 |
| Novo Nordisk | 26 | $503 |
| Dexcom, Inc. | 16 | $499 |
| Bayer | 11 | $373 |
| Abbott | 4 | $178 |
| Corcept Therapeutics | 8 | $168 |
| Mannkind Corporation | 7 | $156 |
| Amgen | 8 | $143 |
| Lilly USA, LLC | 7 | $143 |
| Kyowa Kirin, Inc. | 4 | $114 |
| Tandem Diabetes Care, Inc. | 3 | $109 |
| Sanofi-aventis U.S. LLC | 4 | $101 |
| Xeris Pharmaceuticals, Inc. | 5 | $98 |
| Radius Health, Inc. | 4 | $98 |
| Sequel Med Tech, LLC | 1 | $79 |
| Amphastar Pharmaceuticals, Inc. | 4 | $65 |
| Almatica Pharma LLC | 4 | $63 |
| Ascensia Diabetes Care US Inc. | 2 | $40 |
| Recordati_rare_diseases_inc. | 2 | $39 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Chiesi USA, Inc. | 1 | $27 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Globus Medical | 1 | $21 |
| Boehringer Ingelheim | 1 | $17 |
| Tolmar, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$3,350
- MINIMED 780G$1,215
- Kerendia$244
- DEXCOM G7 GSS (161)$149
- FREESTYLE LIBRE 3$140
- DEXCOM G6 TRANSMITTER$124
- Ozempic$122
How this compares
$8,539 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $76,623 |
| TrulicityDulaglutide | 33 | $48,075 |
| JardianceEmpagliflozin | 32 | $27,441 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $19,628 |
| MounjaroTirzepatide | 18 | $18,997 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $17,222 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $13,177 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,663 |
| Humalog Kwikpen U-100Insulin Lispro | 15 | $4,242 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $4,221 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 20 | $3,980 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 40 | $3,069 |
| Novolog FlexpenInsulin Aspart | 17 | $2,485 |
| HumalogInsulin Lispro | 12 | $2,090 |
| Insulin Lispro | 19 | $1,503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $503 | $78,02472 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $143 | $70,66682 claims |
| Boehringer IngelheimJardiance | $17 | $27,44132 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $34 | $23632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Tucson
- Lindsay CarterTucson$108K
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.